American College of Cardiology
http://www.acc.org

Related Content

2023 MedAxiom Cardiovascular Provider Compensation and Production Survey Report aggregates data on private vs. integrated practice, APP to physician ratios, patient volumes and subspeciality considerations
News | Cardiovascular Business
Cardiology Compensation and Production Remain Relatively Stable Year-over-year

October 4, 2023 — MedAxiom, a premier source for cardiovascular organizational performance solutions, has released its ...

Home October 04, 2023
arrow
New workbook is roadmap to providing quality basic and advanced CV care in the home
News | Cardiovascular Business
ACC Releases Guide to Home-Based Cardiac Care

September 27, 2023 — The healthcare landscape has undergone rapid changes in recent years, requiring clinicians and ...

Home September 27, 2023
arrow
Interim results from SOTERIA open-label extension study represent longest safety and efficacy analysis of sotatercept to date
News | Cardiovascular Clinical Studies
Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...

Home September 12, 2023
arrow
Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL
News | ACC
American College of Cardiology Program to Increase Cholesterol Screenings

September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...

Home September 12, 2023
arrow
Through ACC Global Quality Solutions Program, Dnipro hospital CV teams are enhancing skills and raising quality of care for local heart attack patients
News | ACC
Ukraine Hospital Improving Emergency Cardiovascular Care During National Crisis

May 26, 2023 — The Clinical Hospital of Emergency Services, a municipal hospital serving the community of Dnipro, in ...

Home May 26, 2023
arrow
The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future
News | Cardiovascular Education
Evermed, ACC Launch ACC Anywhere, the 'Netflix of Cardiology'

March 30, 2023 — Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new ...

Home March 30, 2023
arrow
Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.23/WCC) have been announced.
Feature | ACC| By Melinda Taschetta-Millane
ACC 2023 Late-breaking Clinical Trials Announced

Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World ...

Home December 20, 2022
arrow
The Hollywood, Fla. facility - home to the Memorial Cardiac and Vascular Institute - becomes just the fourth hospital in the U.S. to earn advanced certification from the American College of Cardiology
News | Heart Failure
Memorial Regional Hospital Earns Advanced Heart Failure Accreditation

June 9, 2022 — Memorial Regional Hospital recently entered elite company, becoming just the fourth hospital in the ...

Home June 09, 2022
arrow
Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions
News | Cardiovascular Clinical Studies
Biofourmis Selected by ACC as Exclusive Virtual Care Platform to Drive TRANSFORM(3) Study

June 1, 2022 — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced that its ...

Home June 01, 2022
arrow
COMPASS open label extension study results support the long-term use of XARELTO plus aspirin for vascular protection in patients with chronic CAD and/or PAD
News | Cardiovascular Clinical Studies
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition with XARELTO Plus Aspirin in Patients with Coronary Artery Disease, Peripheral Artery Disease

May 31, 2022 — Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and ...

Home May 31, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now